157 related articles for article (PubMed ID: 25934574)
1. Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity.
Li MM; Addepalli B; Tu MJ; Chen QX; Wang WP; Limbach PA; LaSalle JM; Zeng S; Huang M; Yu AM
Drug Metab Dispos; 2015 Jul; 43(7):1129-36. PubMed ID: 25934574
[TBL] [Abstract][Full Text] [Related]
2. Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization.
Wang WP; Ho PY; Chen QX; Addepalli B; Limbach PA; Li MM; Wu WJ; Jilek JL; Qiu JX; Zhang HJ; Li T; Wun T; White RD; Lam KS; Yu AM
J Pharmacol Exp Ther; 2015 Aug; 354(2):131-41. PubMed ID: 26022002
[TBL] [Abstract][Full Text] [Related]
3. Rapid production of novel pre-microRNA agent hsa-mir-27b in Escherichia coli using recombinant RNA technology for functional studies in mammalian cells.
Li MM; Wang WP; Wu WJ; Huang M; Yu AM
Drug Metab Dispos; 2014 Nov; 42(11):1791-5. PubMed ID: 25161167
[TBL] [Abstract][Full Text] [Related]
4. Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs.
Petrek H; Batra N; Ho PY; Tu MJ; Yu AM
Appl Microbiol Biotechnol; 2019 Aug; 103(15):6107-6117. PubMed ID: 31187211
[TBL] [Abstract][Full Text] [Related]
5. Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1.
Pan YZ; Zhou A; Hu Z; Yu AM
Drug Metab Dispos; 2013 Oct; 41(10):1744-51. PubMed ID: 23686318
[TBL] [Abstract][Full Text] [Related]
6. Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1.
Ma J; Wang T; Guo R; Yang X; Yin J; Yu J; Xiang Q; Pan X; Tang H; Lei X
J Drug Target; 2015; 23(6):519-24. PubMed ID: 25714665
[TBL] [Abstract][Full Text] [Related]
7. A general approach to high-yield biosynthesis of chimeric RNAs bearing various types of functional small RNAs for broad applications.
Chen QX; Wang WP; Zeng S; Urayama S; Yu AM
Nucleic Acids Res; 2015 Apr; 43(7):3857-69. PubMed ID: 25800741
[TBL] [Abstract][Full Text] [Related]
8. Expression and Purification of tRNA/ pre-miRNA-Based Recombinant Noncoding RNAs.
Tu MJ; Wright HK; Batra N; Yu AM
Methods Mol Biol; 2021; 2323():249-265. PubMed ID: 34086286
[TBL] [Abstract][Full Text] [Related]
9. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
10. miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells.
Xu K; Liang X; Cui D; Wu Y; Shi W; Liu J
Mol Carcinog; 2013 Jan; 52(1):70-8. PubMed ID: 22121083
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells.
Husted S; Søkilde R; Rask L; Cirera S; Busk PK; Eriksen J; Litman T
Mol Pharm; 2011 Dec; 8(6):2055-62. PubMed ID: 21899346
[TBL] [Abstract][Full Text] [Related]
13. Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition
Li X; Tian Y; Tu MJ; Ho PY; Batra N; Yu AM
Acta Pharm Sin B; 2019 May; 9(3):639-647. PubMed ID: 31193825
[TBL] [Abstract][Full Text] [Related]
14. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
15. miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2.
Xu K; Liang X; Shen K; Cui D; Zheng Y; Xu J; Fan Z; Qiu Y; Li Q; Ni L; Liu J
Biochem J; 2012 Sep; 446(2):291-300. PubMed ID: 22676135
[TBL] [Abstract][Full Text] [Related]
16. Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics.
Yi W; Tu MJ; Liu Z; Zhang C; Batra N; Yu AX; Yu AM
Acta Pharm Sin B; 2020 Jan; 10(1):159-170. PubMed ID: 31993313
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.
Wang ZX; Lu BB; Wang H; Cheng ZX; Yin YM
Arch Med Res; 2011 May; 42(4):281-90. PubMed ID: 21820606
[TBL] [Abstract][Full Text] [Related]
19. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
20. MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17.
Xu K; Liang X; Shen K; Sun L; Cui D; Zhao Y; Tian J; Ni L; Liu J
Exp Cell Res; 2012 Oct; 318(17):2168-77. PubMed ID: 22677042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
